Sionna Therapeutics Inc (NASDAQ:SION)’s traded shares stood at 0.12 million during the last session. At the close of trading, the stock’s price was $21.19, to imply an increase of 1.53% or $0.32 in intraday trading. The SION share’s 52-week high remains $25.19, putting it -18.88% down since that peak but still an impressive 65.74% since price per share fell to its 52-week low of $7.26. The company has a valuation of $935.00M, with an average of 0.4 million shares in intraday trading volume over the past 10 days and average of 182.19K shares over the past 3 months.
Sionna Therapeutics Inc (NASDAQ:SION) trade information
After registering a 1.53% upside in the last session, Sionna Therapeutics Inc (SION) has traded red over the past five days. The 5-day price performance for the stock is 42.89%, and 46.34% over 30 days. Short interest in Sionna Therapeutics Inc (NASDAQ:SION) saw shorts transact 2.83 million shares and set a 19.79 days time to cover.
The extremes give us $45 and $45 for target low and target high price respectively. As such, SION has been trading -112.36% off suggested target high and -112.36% from its likely low.
SION Dividends
Sionna Therapeutics Inc has its next earnings report out on 2025-May-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Sionna Therapeutics Inc (NASDAQ:SION)’s Major holders
Sionna Therapeutics Inc insiders hold 7.20% of total outstanding shares, with institutional holders owning 93.43% of the shares at 100.68% float percentage. In total, 93.43% institutions holds shares in the company.
We also have JPMorgan Trust II-JPMorgan Small Cap Growth Fund and Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund as the top two Mutual Funds with the largest holdings of the Sionna Therapeutics Inc (SION) shares. Going by data provided on Mar 31, 2025, JPMorgan Trust II-JPMorgan Small Cap Growth Fund holds roughly 1.26 shares. This is just over 2.85% of the total shares, with a market valuation of $26.63 million. Data from the same date shows that the other fund manager holds a little less at 553.94, or 1.26% of the shares, all valued at about 11.74 million.
